OLN: Bearish Signal for Olin Corporation - Time for Puts?

Olin Corporation is a global manufacturer and distributor operating in three segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali segment produces chemicals like chlorine, caustic soda, and vinyls intermediates, including 'ethylene dichloride' and 'vinyl chloride monomer', serving industries such as water treatment and PVC production. The Epoxy segment creates epoxy materials and precursors, including 'liquid epoxy resins' and 'solid epoxy resins', targeting applications in wind energy, electrical laminates, and coatings. The 'Winchester' segment manufactures sporting ammunition, reloading components, and small caliber military ammunition, supplying commercial customers, law enforcement, and the U.S. military. Olin differentiates itself by maximizing returns on its Electrochemical Unit in the Chlor Alkali segment, capitalizing on integrated assets in Epoxy, and leveraging its brand strength and manufacturing footprint in Winchester.

No relevant news was found for this stock today.

OLN's technical outlook is decidedly bearish. The stock has experienced a significant downtrend over the past 90 days, evidenced by the recent price action closing at $19.56, substantially below its 50-day SMA of $23.92 and 21-day EMA of $22.74. Momentum indicators reinforce this bearish sentiment; the MACD is negative at -0.86, with the MACD histogram further declining, signaling increasing downward momentum. The RSI is also very low at 34.02, indicating oversold conditions, but in a strong downtrend, this can persist. The Stochastic Oscillator, while in oversold territory, doesn't provide a strong reversal signal yet. The ADX is at 20.84, suggesting a strengthening trend, and the ROC20 is deeply negative at -22.68, highlighting significant recent price declines. The price is also below the lower Bollinger Band, indicating potential for continued downside. Given these factors, a continued downtrend is the most likely scenario for OLN over the next 1-3 months.

Olin Corporation's MD&A presents a somewhat mixed financial picture. For the three months ended September 30, 2025, `Sales` increased to $1,713.2 million compared to $1,589.5 million in the same period last year, an increase of 8%. However, for the nine months ended September 30, 2025, `Gross margin` decreased $109.4 million compared to the prior year period. Gross margin as a percentage of sales decreased to 9% during the nine months ended September 30, 2025 from 12% during the nine months ended September 30, 2024. `Net cash provided by operating activities` decreased by $208.5 million from the nine months ended September 30, 2024, to $153.0 million, primarily due to a larger increase in working capital and lower operating results. The company anticipates a more difficult fourth quarter due to 'continued global uncertainty and related cautious customer buying patterns', expecting results to decline from the third quarter in both its chemicals and Winchester businesses. While Olin benefits from a $32.0 million pretax benefit related to the 45V tax credit in Chlor Alkali Products and Vinyls, the overall outlook suggests potential headwinds in the near term.

Olin's Q2 2025 earnings call reveals a mixed performance and a cautious outlook. While management highlights the resilience of their 'Value First' commercial approach, several headwinds impacted results. Ken Lane noted that Q2 results were at 'the low end of our second quarter outlook' due to unplanned operating events. The Winchester commercial ammunition business faces a 'perfect storm' due to customer destocking, lower commercial pricing, and higher raw material costs. Although the defense business remains strong, the commercial side is challenged. In chlor-alkali, EDC pricing declined more sharply than expected, offsetting caustic soda strength. The company anticipates third quarter adjusted EBITDA to be in the range of $170 to $210 million, reflecting ongoing macroeconomic and tariff uncertainty. While seasonal demand strength is expected across Olin's businesses, Winchester's typical seasonal peak will be below normal levels. The potential for retaliatory tariffs from Brazil on caustic soda exports adds further uncertainty. Despite these challenges, Olin is focused on cost savings through the Beyond 250 project and remains committed to disciplined capital allocation, prioritizing debt reduction and shareholder returns.

OLN's financial performance presents a mixed picture. Revenue has fluctuated, starting at $1635.3M in Q1 2024, peaking at $1758.3M in Q2 2025, and then declining to $1713.2M in the most recent quarter (Q3 2025). The gross profit ratio has also been inconsistent, with a high of 0.141 in Q2 2024 and a low of 0.078 in Q2 2025, settling at 0.107 in Q3 2025. Operating cash flow has been volatile, shifting from $81M in Q1 2024 to a negative -$126.3M in Q3 2025, raising concerns about short-term liquidity. Total debt has increased from $3108M in Q1 2024 to $3243.6M in Q3 2025, indicating a slight increase in leverage. The inconsistent profitability, volatile cash flow, and increasing debt suggest potential financial strain, warranting caution despite the relatively stable revenue.

The company demonstrates a moderately bullish profile, characterized by solid revenue growth and improving profitability. Revenue has consistently increased, indicating strong market demand. The gross margin exhibits stability, suggesting efficient cost management. Return on Equity (ROE) has shown positive movement, signaling enhanced profitability and efficient use of shareholder equity. The Price-to-Earnings (P/E) ratio, while elevated, might be justifiable given the growth trajectory and positive ROE trend. The Debt-to-Equity ratio shows a slight increase, which warrants monitoring, but is counterbalanced by a healthy Current Ratio, implying sufficient liquidity to meet short-term obligations. Overall, the company presents a favorable picture with growth and profitability, though the leverage should be watched closely. The combination of growth and profitability suggests potential for continued positive performance over the next 12 months.